Stille

Stille Net Margin

The Net Profit Margin of Stille (STIL.ST) as of Oct 24, 2026 is 9.81 %. In the previous year, Net Profit Margin was 10.21 % — a change of -3.91% (lower).

Net Margin

9.81 %

YoY

-3.91%

Last updated:

Net Profit Margin of Stille is 2025 9.81 % . Net Profit Margin of Stille was 2024 10.21 % . It decreases by -3.91% lower compared to the previous year.

For Stille, the net margin of 9.8% is up versus 8.6% a few years ago.

The Stille Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
14.86 SEK
Jan 1, 2019
14.60 SEK
Jan 1, 2020
5.80 SEK
Jan 1, 2021
8.60 SEK
Jan 1, 2022
11.09 SEK
Jan 1, 2023
9.04 SEK
Jan 1, 2024
10.21 SEK
Jan 1, 2025
9.81 SEK
The Stille Net Margin history
YEARNet MarginYoY
9.81 %-3.91%
10.21 %+13.02%
9.04 %-18.53%
11.09 %+28.91%
8.60 %+48.33%
5.80 %-60.28%
14.60 %-1.73%
14.86 %+27.54%
11.65 %-33.15%
17.43 %+38.61%
12.57 %+441.96%
2.32 %+6,186.39%
0.04 %-269.58%
-0.02 %+85.81%
-0.01 %-128.03%
0.04 %-20.15%
0.05 %-385.10%
-0.02 %-72.36%
-0.07 %-73.83%
-0.25 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

Net Profit Margin of Stille is 9.81 % in 2025.

Net Profit Margin of Stille changed from 10.21 % to 9.81 %, representing a -3.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Stille since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Stille with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Stille

All Key Metrics — Stille